🇺🇸 FDA
Pipeline program

BAX 826

291501

Phase 1 mab completed

Quick answer

BAX 826 for Hemophilia A is a Phase 1 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Hemophilia A
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials